Quantitative Measures of Time to Loss of 15% Vital Capacity and Survival Extension in Slowly Progressive Amyotrophic Lateral Sclerosis (ALS) Patients Treated with the Immune Regulator NP001 Suggests an Immunopathogenic Subset of ALS

  • Namita A. Goyal
  • , Jinsy A. Andrews
  • , Björn E. Oskarsson
  • , Martina H. Wiedau
  • , Edward J. Kasarskis
  • , Bruce D. Forrest
  • , Rongzhen Zhang
  • , Paige M. Bracci
  • , Matthew W. Davis
  • , Ari Azhir
  • , Michael S. McGrath

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Quantitative Measures of Time to Loss of 15% Vital Capacity and Survival Extension in Slowly Progressive Amyotrophic Lateral Sclerosis (ALS) Patients Treated with the Immune Regulator NP001 Suggests an Immunopathogenic Subset of ALS'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology